Solanke Dattatray, Rathi Chetan, Pandey Vikas, Patil Mallanagoud, Phadke Aniruddha, Sawant Prabha
Department of Gastroenterology, Lokmanya Tilak Municipal Medical College and General Hospital, Sion, Mumbai, 400 022, India.
Indian J Gastroenterol. 2016 Nov;35(6):450-458. doi: 10.1007/s12664-016-0704-6. Epub 2016 Oct 31.
The aim of this study is to study the etiology, clinical profile, and prognostic factors related to maternal and fetal health in pregnant patients with liver disease in Western India.
This study included 103 consecutive pregnant patients with liver dysfunction from August 2013 to July 2015, who underwent regular biochemical tests, viral markers, ultrasound of abdomen, etc. and were followed up for 6 weeks postpartum or until death.
Pregnancy-specific causes of liver dysfunction were found in 39 % (40/103) patients. Liver diseases were most frequent in third trimester 69.9 % (72/103). Etiologies in third trimester were viral hepatitis 36.1 % (26/72), pregnancy induced hypertension (PIH) 30.5 % (22/72), intrahepatic cholestasis of pregnancy 11.1 % (8/72), acute fatty liver of pregnancy (2/72), etc. Hepatitis E was the commonest agent among viral hepatitis 71.8 % (28/39). Causes of maternal mortality (n = 25) were hepatitis E 40 % (10/25), PIH 32 % (8/25), and tropical diseases 20 % (5/25). Fetal mortality (n = 31) was 38.7 % (12/31) in hepatitis E. Maternal mortality was significantly associated with presence of jaundice, fever, abdominal pain, oliguria, anemia, leukocytosis, and coagulopathy. Model for end-stage liver disease (MELD) score >21 predicted maternal mortality with 80 % sensitivity and 91 % specificity (area under the receiver operating characteristic curve = 0.878 and p < 0.001).
Liver disease was most common in the third trimester of pregnancy. Hepatitis E was the most common cause of liver disease in pregnant women in western India with significant maternal mortality, predicted by high MELD score.
本研究旨在探讨印度西部肝病孕妇中与母婴健康相关的病因、临床特征及预后因素。
本研究纳入了2013年8月至2015年7月期间103例连续的肝功能不全孕妇,她们接受了常规生化检查、病毒标志物检测、腹部超声等检查,并在产后6周或直至死亡进行随访。
39%(40/103)的患者发现了与妊娠相关的肝功能障碍病因。肝病在妊娠晚期最为常见,占69.9%(72/103)。妊娠晚期的病因包括病毒性肝炎36.1%(26/72)、妊娠高血压综合征(PIH)30.5%(22/72)、妊娠期肝内胆汁淤积症11.1%(8/72)、妊娠急性脂肪肝(2/72)等。戊型肝炎是病毒性肝炎中最常见的病原体,占71.8%(28/39)。孕产妇死亡原因(n = 25)为戊型肝炎40%(10/25)、PIH 32%(8/25)和热带疾病20%(5/25)。戊型肝炎胎儿死亡率(n = 31)为38.7%(12/31)。孕产妇死亡与黄疸、发热、腹痛、少尿、贫血、白细胞增多和凝血障碍显著相关。终末期肝病模型(MELD)评分>21预测孕产妇死亡的敏感性为80%,特异性为91%(受试者操作特征曲线下面积 = 0.878且p < 0.001)。
肝病在妊娠晚期最为常见。戊型肝炎是印度西部孕妇肝病的最常见原因,孕产妇死亡率高,高MELD评分可预测。